Publicacións nas que colabora con Eduardo Sobarzo Sánchez (23)

2019

  1. Aporphines and Alzheimer's Disease: Towards a Medical Approach Facing the Future

    Current medicinal chemistry, Vol. 26, Núm. 18, pp. 3253-3259

  2. In silico prediction of P-glycoprotein binding: Insights from molecular docking studies

    Current Medicinal Chemistry, Vol. 26, Núm. 10, pp. 1746-1760

  3. Potent in Vitro α-Glucosidase Inhibition of Secondary Metabolites Derived from Dryopteris cycadina

    Molecules, Vol. 24, Núm. 3

  4. Quercetin and related chromenone derivatives as monoamine oxidase inhibitors: Targeting neurological and mental disorders

    Molecules, Vol. 24, Núm. 3

2018

  1. Alkaloids as MAO-A inhibitors: Towards the final solution for depression and anxiety

    Psychiatric and Mood Diseases and the Natural Compounds: An Approach to the Future Medical Tool (Nova Science Publishers, Inc.), pp. 169-192

  2. Ligand and structure-based modeling of passive diffusion through the blood-brain barrier

    Current Medicinal Chemistry, Vol. 25, Núm. 9, pp. 1073-1089

  3. Nanomedicine and Parkinson’s disease: A nanoparticle medical approach

    Psychiatric and Mood Diseases and the Natural Compounds: An Approach to the Future Medical Tool (Nova Science Publishers, Inc.), pp. 153-168

2017

  1. A medical approach to the monoamine oxidase inhibition by using 7H-benzo[e]perimidin-7-one derivatives

    Current Topics in Medicinal Chemistry, Vol. 17, Núm. 7

  2. Aporphine alkaloids and their antioxidant medical application: From antineoplastic agents to motor dysfunction diseases

    Current Organic Chemistry, Vol. 21, Núm. 4, pp. 342-347

  3. Molecular docking and drug discovery in β-adrenergic receptors

    Current Medicinal Chemistry, Vol. 24, Núm. 39, pp. 4340-4359

2016

  1. Aporphines and parkinson’s disease: Medical tools for the future

    Current Topics in Medicinal Chemistry, Vol. 16, Núm. 17, pp. 1906-1909

2015

  1. Anxiolytic-like effects of 7H-benzo[e]perimidin-7-one derivatives through elevated plus-maze test in mice

    Current Topics in Medicinal Chemistry, Vol. 15, Núm. 17, pp. 1750-1754

  2. Nanoparticles in the treatment of mental disorders: A new tool in the psychiatric medication

    Current Topics in Medicinal Chemistry, Vol. 15, Núm. 4, pp. 282-286

2014

  1. Comparison of the antidepressive effects of trans-resveratrol and 5-methoxy-7H-dibenzo[de,h]quinolin-7-one.

    Current topics in medicinal chemistry, Vol. 14, Núm. 2, pp. 234-238

  2. Cyclodextrin-based polysaccharidic polymers: An approach for the drug delivery

    Current Topics in Medicinal Chemistry, Vol. 14, Núm. 4, pp. 542-551

2013

  1. Host-guest interaction between new nitrooxoisoaporphine and β-cyclodextrins: Synthesis, electrochemical, electron spin resonance and molecular modeling studies

    Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, Vol. 102, pp. 226-234

  2. Synthetic oxoisoaporphine alkaloids: in vitro, in vivo and in silico assessment of antileishmanial activities.

    PloS one, Vol. 8, Núm. 10

2012

  1. Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: Implications in drug solubilization and delivery

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 80, Núm. 3, pp. 585-595

  2. Monoamino oxidase A: An interesting pharmacological target for the development of multi-target QSAR

    Mini-Reviews in Medicinal Chemistry, Vol. 12, Núm. 10, pp. 947-958

2011

  1. 2D MI-DRAGON: A new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins

    European Journal of Medicinal Chemistry, Vol. 46, Núm. 12, pp. 5838-5851